TotalMarketCap

Rocket One

RKTONasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$10.006 M

$0.40 -9.11%

Close of 6 Nov 2026

As of 6 Nov 2026, Rocket One (RKTO) has a market capitalization of $10.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$12.5M

Loss-making

Shares outstanding

24,897,581

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #414Chemomab TherapeuticsCMMB$10.3M
  2. #415Azora Therapeutics, Inc. (DE)AZR$10.0M
  3. #416Rocket OneRKTO$10.0M
  4. #417Aspire-LakewoodASBP$9.58M
  5. #418GT BiopharmaGTBP$9.44M

What if Rocket One were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,134,121

Per share 2,821,899× higher

Bitcoin $1.53T

$61,365.32

Per share 152,688× higher

Apple $5.02T

$201,456.62

Per share 501,261× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Rocket One are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.